Cutaneous Richter syndrome: a better place to transform?

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Richter syndrome (RS) is a transformation of chronic lymphocytic leukemia (CLL) into aggressive lymphoma.
• RS carries a grave prognosis with a median survival of approximately 8 months, even with treatment.

Observation:

• Cutaneous RS, a rare variant, has been reported in a limited number of cases.
• This form of RS may present with a more favorable outcome compared to extracutaneous manifestations.

Findings:

• Literature review focusing on pathogenesis, treatment, and survival of RS.
• Postulated factors for better cutaneous RS survival include absence of B symptoms, normal lactate dehydrogenase, and lower tumor burden, suggesting localized disease.

Implications:

• Understanding the distinct characteristics of cutaneous RS is crucial for patient management.
• Further research into the specific mechanisms driving better outcomes in cutaneous RS could inform novel therapeutic strategies.
• The findings highlight the importance of considering disease localization and tumor burden in predicting RS prognosis.